Published online Aug 31, 2008.
https://doi.org/10.4055/jkoa.2008.43.4.479
HIF-1α and VEGF Expression in Fracture Healing
Abstract
Purpose
To elucidate the relation between fracture healing and angiogenesis, we checked expression of Hypoxia-inducible factor (HIF) and Vascular endothelial growth factor (VEGF) in hypoxic cell cultures and the callus from a rat femur fracture model.
Materials and Methods
Human osteoblasts, chondrocytes, and rat ST2 cells were cultured in DME/F12 media with 10% FBS. Hypoxic DME/F12 media (PO2<60 mmHg) was generated by bubbling with 95% N2 and 5% CO2 and added to cells. After 2, 6, and 24 hours, RNA and proteins were collected for reverse transcription - polymerase chain reaction (RT-PCR) and Western blot. In addition, immunocytochemistry and siRNA treatment for HIF-1α were performed. Next, femurs from 9-week SD rats were fractured after fixation with needles. The rats were sacrificed at post-fracture day (PFD) 3, 5, 7, 10, 14, 21 and calluses were collected for RT-PCR and Western blot.
Results
HIF-1α and HIF-2α expression were not increased in RT-PCR but protein levels were increased. VEGF expression in RT-PCR was increased. Treatment with siRNA directed towards HIF inhibited VEGF expression. In the rat fracture callus, HIF-1α and VEGF expression peaked between PFD 5 and 7 and decreased after PFD 10. In contrast to cell culture, mRNA expression of HIF-1α was increased at PFD 7.
Conclusion
HIF-1α and VEGF peaked early in fracture healing. With expression decreasing as O2 tension increased. Further study is needed to identify other factors affecting chondrogenic differentiation.
Fig. 1
Hypoxia does not induce HIF-1α mRNA expression (A, B) but increases protein levels (C, D). N, normoxia; H, hypoxia.
Fig. 2
Hypoxia does not induce HIF-2α mRNA expression (A, B) but increases protein levels (C, D).
Fig. 3
Hypoxia increases VEGF mRNA expression in ST2 cells (A) and chondrocytes (B).
Fig. 4
Hypoxia does not induce HIF-1α and HIF-2α mRNA expression but increases protein levels. HIF-1α, HIF-2α and VEGF expression in human osteoblasts shows similar expression patterns to ST2 cells and chondrocytes.
Fig. 5
Human chondrocyte immunocytochemistry shows increased expression of HIF and VEGF in hypoxia.
Fig. 6
VEGF expression was decreased by treatment with siRNA for HIF-1α in human osteoblasts. Mock, transfection control.
Fig. 7
VEGF expression was decreased by treatment with siRNA for HIF-1α in human chondrocytes. Mock, transfection control.
Fig. 8
Western blot for HIF-1α in callus shows elevation at early stages of fracture healing (peak at PFD 5) and decreases after PFD 10.
Fig. 9
RT-PCR for HIF-1α in callus shows elevation at early stages of fracture healing (peak at PFD 7).
Fig. 10
RT-PCR for VEGF in callus shows elevation at early stages of fracture healing (peak at PFD 5) and decreases after PFD 10.
References
-
Brighton CT, Hunt RM. Early histological and ultrastructural changes in medullary fracture callus. J Bone Joint Surg Am 1991;73:832–847.
-
-
Gleadle JM, Ebert BL, Firth J, Ratcliffe PJ. Regulation of angiogenic growth factor expression by hypoxia, transition metals, and chelating agents. Am J Physiol 1995;268:C1362–C1368.
-
-
Goldberg MA, Schneider TJ. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin . J Biol Chem 1994;269:4355–4359.
-
-
Jelkmann W. Erythropoitin: structure, control of production, and function. Physiol Rev 1992;72:449–489.
-
-
Krishnamachary B, Berg-Dixon S, Kelly B, et al. Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res 2003;63:1138–1143.
-
-
Marsh D. Concepts of fracure union, delayd union, and nonunion. Clin Orthop Relat Res 1998;355 Suppl 355:S22–S30.
-
-
Mizuno K, Mieno K, Tachibana T, Sumi M, Hirohata K. The osteogenetic potential of fracture haematoma. Subperiosteal and intramuscular transplantation of the haematoma. J Bone Joing Surg Br 1990;72:822–829.
-
-
Pufe T, Wildemann B, Petersen W, Mentlein R, Raschke M, Schmidmaier G. Quantitative measurement of the spilce variants 120 and 164 of the angiogenic peptide vascular endothelial growth factor in the time flow of fracture healing: a study in the rat. Cell Tissue Res 2002;309:382–392.
-